Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study-Reference-Cited by-同舟云学术

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Published:2015-06-25 Issue:5 Volume:87 Page:468-475
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Cohen Jeffrey A,Khatri Bhupendra,Barkhof Frederik,Comi Giancarlo,Hartung Hans-Peter,Montalban Xavier,Pelletier Jean,Stites Tracy,Ritter Shannon,von Rosenstiel Philipp,Tomic Davorka,Kappos Ludwig

Publisher

BMJ

Subject

Psychiatry and Mental health,Clinical Neurology,Surgery

Reference17 articles.

1. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

2. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study;Khatri;Lancet Neurol,2011

3. 2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster Session 1;Mult Scler,2014

4. Measures in the first year of therapy predict the response to interferon beta in MS;Rio;Mult Scler,2009

5. Hy's law: predicting serious hepatotoxicity;Temple;Pharmacoepidemiol Drug Saf,2006

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. [Translated article] Risk of Skin Cancer Associated with Disease-Modifying Therapies in Multiple Sclerosis: A Comprehensive Evidence Review;Actas Dermo-Sifiliográficas;2024-09

3. Riesgo de cáncer cutáneo asociado a terapias modificadoras de la enfermedad en la esclerosis múltiple: revisión narrativa de la evidencia actual;Actas Dermo-Sifiliográficas;2024-09

4. Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod;Journal of Neurology;2024-08-23

5. Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database;Journal of the Neurological Sciences;2024-08